G protein-coupled receptor

5-HT2B receptor

5-hydroxytryptamine receptor 2B

The 5-HT2B receptor belongs to the same group as 5-HT2A and 5-HT2C. Like them it is a G protein-coupled receptor that is linked to phospholipase C.1 In cells that carry the human receptor, agonists cause a rapid rise in calcium inside the cell.2

Norfenfluramine, a metabolite of the diet drug fenfluramine, binds with high affinity to the human 5-HT2B receptor and activates it. Fenfluramine was associated with valvular heart disease, and a screen of drugs with this side effect implied that activating the receptor is necessary to cause it.3 MDMA and its metabolite MDA also bind to and activate the human receptor. In cultured human heart valve cells, both caused prolonged cell division, as norfenfluramine does.4

Sources (4)
  1. Burns et al. 1997Burns CM, Chu H, Rueter SM, et al. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing Nature
  2. Porter et al. 1999Porter RH, Benwell KR, Lamb H, et al. (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells Br J Pharmacol
  3. Rothman et al. 2000Rothman RB, Baumann MH, Savage JE, et al. (2000) Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications Circulation
  4. Setola et al. 2003Setola V, Hufeisen SJ, Grande-Allen KJ, et al. (2003) 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro Mol Pharmacol

Binding affinity (Kᵢ)

19 substances, 23 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.

Human

19 measurements
  • LSDAgonistunresolved5.5 nMJain et al. 2025 · 3 reports
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
    Range
    0.57–5.5 nM in 3 reports

    Reported values disagree and no value is established. 4 reports in all, 0.57–30 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Jain et al. 20255.5 nMTable S4
    Eshleman et al. 20180.57 nMTable 1
    Wacker et al. 20133.7 nMSupplement, Table S2
  • BufoteninAgonistunresolved6.2 nMJain et al. 2025 · 2 reports
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
    Range
    6.2–631 nM in 2 reports

    Reported values disagree and no value is established. 2 reports in all, 6.2–631 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Jain et al. 20256.2 nMTable S4
    Colas et al. 1997631 nMTable 1
  • PsilocinAgonistunresolved8.0 nMGlatfelter et al. 2022 · 2 reports
    Assay
    Transfected-cell radioligand binding at human 5-HT2B (UNC PDSP)
    Shown value from
    Glatfelter et al. 2022, Table 1
    Range
    8.0–25 nM in 2 reports

    Reported values disagree and no value is established. 3 reports in all, 4.7–25 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Glatfelter et al. 20228.0 nMTable 1
    Jain et al. 202525 nMTable S4
  • 4-HO-MET12 nMGlatfelter et al. 2023
    Assay
    human 5-HT2B receptor, [3H]LSD competition binding (NIMH PDSP)
    Shown value from
    Glatfelter et al. 2023, Table 2
  • 2C-BAgonist14 nMRay 2010
    Assay
    PDSP receptorome (compiled; species not stated per entry, predominantly human clones)
    Shown value from
    Ray 2010, Table S2 (AllKiData)
  • AL-LADAgonist14 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • ETH-LADAgonist18 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • DOIAgonistunresolved20 nMNelson et al. 1999 · 3 reports
    Assay
    cloned human 5-HT2B receptor in AV12 cells; agonist-radioligand [3H]5-HT binding
    Shown value from
    Nelson et al. 1999, Table 1
    Range
    5.0–20 nM in 3 reports
    Error
    ± 3.6 SEM, n = 3

    Reported values disagree and no value is established. 4 reports in all, 5.0–336 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Nelson et al. 199920 nMTable 1
    Jain et al. 20255.6 nMTable S4
    Glatfelter et al. 20225.0 nMTable 1
  • 2C-EAgonist25 nMRay 2010
    Assay
    PDSP receptorome (compiled; species not stated per entry, predominantly human clones)
    Shown value from
    Ray 2010, Table S2 (AllKiData)
  • DOBAgonistunresolved27 nMNelson et al. 1999
    Assay
    cloned human 5-HT2B receptor in AV12 cells; agonist-radioligand [3H]5-HT binding
    Shown value from
    Nelson et al. 1999, Table 1
    Error
    ± 4.6 SEM, n = 3

    Reported values disagree and no value is established. 2 reports in all, 3.9–27 nM.

  • 5-MeO-DMTAgonistother reports differ36 nMHalberstadt et al. 2012 · 4 reports
    Assay
    cloned human receptor; [3H]LSD competition binding (NIMH PDSP)
    Shown value from
    Halberstadt et al. 2012, Table 1
    Range
    15–6310 nM in 4 reports
    Error
    ± 6.0 SEM

    This is the best-supported value. Other reports differ. 5 reports in all, 15–6310 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Halberstadt et al. 201236 nMTable 1
    Jain et al. 202515 nMTable S4
    Glatfelter et al. 202419 nMSupplement Figure S1
    Colas et al. 19976310 nMTable 1
  • DOMAgonistunresolved41 nMEshleman et al. 2018 · 3 reports
    Assay
    recombinant human 5-HT2B receptor; [3H]5-HT competition binding
    Shown value from
    Eshleman et al. 2018, Table 1
    Range
    7.8–149 nM in 3 reports
    Error
    ± 5.9 SEM, n = 3

    Reported values disagree and no value is established. 4 reports in all, 7.8–149 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Luethi et al. 2026149 nMTable 1
    Eshleman et al. 201841 nMTable 1
    Jain et al. 20257.8 nMTable S4
  • 5-MeO-MiPTAgonist53 nMGlatfelter et al. 2024
    Assay
    human 5-HT2B receptor, [3H]LSD competition binding
    Shown value from
    Glatfelter et al. 2024, Supplement Figure S1
  • MDAAgonist91 nMRay 2010
    Assay
    PDSP receptorome (compiled; species not stated per entry, predominantly human clones)
    Shown value from
    Ray 2010, Table S2 (AllKiData)
  • DMTAgonist110 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • PsilocybinAgonist259 nMGlatfelter et al. 2022 · 2 reports
    Assay
    Transfected-cell radioligand binding at human 5-HT2B (UNC PDSP)
    Shown value from
    Glatfelter et al. 2022, Table 1
    Range
    259–480 nM in 2 reports
    Sources and values behind the range, same assay family
    ReportValueWhere
    Glatfelter et al. 2022259 nMTable 1
    Jain et al. 2025480 nMTable S4
  • MDMAAgonist270 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • MescalineAgonist400 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • Methylone1800 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4

Bovine

1 measurement
  • PsilocinAgonistsource not traced410 nMDodd et al. 2023
    Assay
    5-HT2B binding, compiled in a review (Table 2), original assay not restated
    Shown value from
    Dodd et al. 2023, Table 2

Mouse

1 measurement
  • BufoteninAgonist1585 nMColas et al. 1997
    Assay
    mouse 5-HT2B receptor expressed in COS-1 cells, [125I]DOI competition binding
    Shown value from
    Colas et al. 1997, Table 1

Unspecified

2 measurements
  • PsilocinAgonistsource not traced4.6 nMDodd et al. 2023
    Assay
    5-HT2B binding, compiled in a review (Table 2), original assay not restated
    Shown value from
    Dodd et al. 2023, Table 2
  • DMTAgonist184 nMKeiser et al. 2009
    Assay
    NIMH PDSP radioligand competition binding at the 5-HT2B receptor, [3H]LSD (1.0 nM), standard binding buffer
    Shown value from
    Keiser et al. 2009, Supplementary Table 4

Functional potency (EC₅₀)

23 substances, 26 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.

Human

23 measurements
  • DOBAgonist2.9 nMPorter et al. 1999 · 2 reports
    Assay
    CHO-K1 cells stably expressing recombinant human 5-HT2B; FLIPR calcium mobilization
    Shown value from
    Porter et al. 1999, Table 1
    Range
    2.9–8.7 nM in 2 reports
    Emax
    69.0%
    Sources and values behind the range, same assay family
    ReportValueWhere
    Porter et al. 19992.9 nMTable 1
    Hemanth et al. 20238.7 nMTable 1-B
  • LSDAgonistdepends on assay3.1 nMEshleman et al. 2018
    Assay
    recombinant human 5-HT2B receptor; IP-1 formation
    Shown value from
    Eshleman et al. 2018, Table 2
    Error
    ± 0.65 SEM, n = 6
    Emax
    23.3 ± 4.9%

    Values depend on the assay, species or conditions, and each is valid only for its own. 7 reports in all, 0.68–40 nM.

  • BufoteninAgonist6.2 nMJain et al. 2025
    Assay
    5-HT2B receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
  • DOIAgonistother reports differ6.9 nMJain et al. 2025 · 2 reports
    Assay
    5-HT2B receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
    Range
    1.4–6.9 nM in 2 reports
    Emax
    99.8 ± 0.8%

    This is the best-supported value. Other reports differ. 2 reports in all, 1.4–6.9 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Porter et al. 19991.4 nMTable 1
    Jain et al. 20256.9 nMTable S6
  • PsilocinAgonistother reports differ8.0 nMGlatfelter et al. 2022 · 3 reports
    Assay
    cells expressing human 5-HT2B; calcium mobilization
    Shown value from
    Glatfelter et al. 2022, Table 4
    Range
    2.4–8.0 nM in 3 reports
    Emax
    38.0%

    This is the best-supported value. Other reports differ. 3 reports in all, 2.4–8.0 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Klein et al. 20202.4 nMTable 3
    Glatfelter et al. 20228.0 nMTable 4
    Jain et al. 20257.8 nMTable S6
  • 5-MeO-DMTAgonistunresolved11 nMGlatfelter et al. 2024
    Assay
    Transfected cells expressing human 5-HT2B; Galpha-q dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Emax
    73.0%

    Reported values disagree and no value is established. 4 reports in all, 5.9–20 nM.

  • 5-MeO-MiPTAgonistother reports differ50 nMGlatfelter et al. 2024
    Assay
    Transfected cells expressing human 5-HT2B; Galpha-q dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Emax
    87.9%

    This is the best-supported value. Other reports differ. 3 reports in all, 44–1500 nM.

  • ETH-LADAgonist58 nMJain et al. 2025
    Assay
    5-HT2B receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
    Emax
    100.8 ± 81.2%
  • AL-LADAgonist100 nMJain et al. 2025
    Assay
    5-HT2B receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
    Emax
    95.0 ± 1.6%
  • 2C-BAgonist130 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 60 SD
    Emax
    89.0 ± 13.0%
  • 2C-PAgonist130 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 10 SD
    Emax
    72.0 ± 18.0%
  • 6-APBAgonist140 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B receptor, functional activation
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 60 SD
    Emax
    70.0 ± 9.0%
  • DOMAgonistdepends on assay145 nMEshleman et al. 2018 · 2 reports
    Assay
    recombinant human 5-HT2B receptor; IP-1 formation
    Shown value from
    Eshleman et al. 2018, Table 2
    Range
    145–688 nM in 2 reports
    Error
    ± 47 SEM, n = 4
    Emax
    96.2 ± 3.2%

    Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 6.6–688 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Luethi et al. 2026688 nMTable 1
    Eshleman et al. 2018145 nMTable 2
  • 2C-IAgonist150 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 100 SD
    Emax
    70.0 ± 18.0%
  • 2C-EAgonist190 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 40 SD
    Emax
    66.0 ± 7.0%
  • 2C-DAgonist230 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 70 SD
    Emax
    77.0 ± 17.0%
  • 2C-CAgonist280 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 110 SD
    Emax
    81.0 ± 14.0%
  • 5-APBAgonist280 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B receptor, functional activation
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 120 SD
    Emax
    61.0 ± 17.0%
  • MescalineAgonist500 nMJain et al. 2025
    Assay
    5-HT2B receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
    Emax
    87.2 ± 1.8%
  • PsilocybinAgonist612 nMGlatfelter et al. 2022
    Assay
    cells expressing human 5-HT2B; calcium mobilization
    Shown value from
    Glatfelter et al. 2022, Table 4
    Emax
    38.0%
  • MDMAAgonist620 nMJain et al. 2025
    Assay
    5-HT2B receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
    Emax
    41.4 ± 3.0%
  • MDAAgonist850 nMRickli et al. 2015
    Assay
    cloned human 5-HT2B receptor, functional activation
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 110 SD
    Emax
    52.0 ± 12.0%
  • DMTAgonistunresolved3400 nMRickli et al. 2016 · 2 reports
    Assay
    HEK293 cells expressing human 5-HT2B; Fluo-4 calcium mobilization
    Shown value from
    Rickli et al. 2016, Table 1
    Range
    71–3400 nM in 2 reports
    Error
    ± 3200 SD
    Emax
    19.0 ± 6.0%

    Reported values disagree and no value is established. 2 reports in all, 71–3400 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 20163400 nMTable 1
    Jain et al. 202571 nMTable S6

Mouse

2 measurements
  • PsilocinAgonistsource not traced58 nMPlazas et al. 2023
    Assay
    5-HT2B receptor, compiled in a review table (Table 5), original assay not restated
    Shown value from
    Plazas et al. 2023, Table 5
  • PsilocybinAgonistsource not traced74 nMPlazas et al. 2023
    Assay
    5-HT2B receptor, compiled in a review table (Table 5), original assay not restated
    Shown value from
    Plazas et al. 2023, Table 5

Unspecified

1 measurement
  • LSDAgonist0.55 nMBasargin et al. 2026
    Assay
    HEK293T cells transiently expressing 5-HT2B with Gαq-RLuc8, human Gβ3 and GFP2-Gγ9, Gq dissociation BRET2
    Shown value from
    Basargin et al. 2026, SI Table S2, p. S19
    Emax
    71.3 ± 2.2%

Also reported to act here

Substances reported to act here, without a displayed value.

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.